New analogues (3a-l) of the previously described α4β2 selective ligand 3-(6-halopyridin-3-yl)-3,6-diazabicyclo[3.1.1]heptanes (2a,b) have been synthesized and their binding activity for neuronal acetylcholine receptor subtypes α4β2 and α7 were assayed.Six of these compounds (3a,b,c,j,k and l) showed high affinity and selectivity for α4β2 receptors. The phenylpyridyl-diazabicycloheptane 3c displayed Ki value of 11.17 pM for α4β2, in line with that of the halogenated homologues 3a,b, although it was characterized by an improved selectivity (Ki = 17 μM for α7 receptors). The influence of substitutions on the phenylpyridyl moiety on binding at both α4β2 and α7 receptors has been examined through the Topliss decision tree analysis. Substitution with electron-donating groups (as CH3 and OCH3) resulted in a good affinity for α4β2 receptors and substantially no affinity for α7. Amongst all the tested phenyl-substituted compounds, the p-NO2-phenyl substituted analogue 3j exhibited the highest α4β2 affinity, with Ki value comparable to that of 3c.Intrinsic α4β2 receptor mediated activity in [3H]-DA release assay was showed by compound 3a as well as by the reference analogue 2a, whereas phenyl substituted derivative 3c exhibited α4β2 antagonist activity.

Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors / Deligia, F; Deiana, V; Gotti, C; Lazzari, P; Bottazzi, Meh; Pucci, L; Fasoli, F; Ragusa, G; Pinna, Gerard Aime; Murineddu, Gabriele. - In: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0223-5234. - 103:(2015), pp. 429-437. [10.1016/j.ejmech.2015.09.006]

Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors

PINNA, Gerard Aime;MURINEDDU, Gabriele
2015-01-01

Abstract

New analogues (3a-l) of the previously described α4β2 selective ligand 3-(6-halopyridin-3-yl)-3,6-diazabicyclo[3.1.1]heptanes (2a,b) have been synthesized and their binding activity for neuronal acetylcholine receptor subtypes α4β2 and α7 were assayed.Six of these compounds (3a,b,c,j,k and l) showed high affinity and selectivity for α4β2 receptors. The phenylpyridyl-diazabicycloheptane 3c displayed Ki value of 11.17 pM for α4β2, in line with that of the halogenated homologues 3a,b, although it was characterized by an improved selectivity (Ki = 17 μM for α7 receptors). The influence of substitutions on the phenylpyridyl moiety on binding at both α4β2 and α7 receptors has been examined through the Topliss decision tree analysis. Substitution with electron-donating groups (as CH3 and OCH3) resulted in a good affinity for α4β2 receptors and substantially no affinity for α7. Amongst all the tested phenyl-substituted compounds, the p-NO2-phenyl substituted analogue 3j exhibited the highest α4β2 affinity, with Ki value comparable to that of 3c.Intrinsic α4β2 receptor mediated activity in [3H]-DA release assay was showed by compound 3a as well as by the reference analogue 2a, whereas phenyl substituted derivative 3c exhibited α4β2 antagonist activity.
2015
Inglese
103
429
437
9
http://www.journals.elsevier.com/european-journal-of-medicinal-chemistry/
Esperti anonimi
No
3,6-diazabicyclo[3.1.1]heptanes; Agonism; Antagonism; Synthesis; α4β2 neuronal nicotinic acetylcholine receptors selectivity; Animals; Azabicyclo Compounds; Binding Sites; Dose-Response Relationship, Drug; Humans; Molecular Structure; Rats; Receptors, Nicotinic; Structure-Activity Relationship; Drug Design; Drug Discovery3003 Pharmaceutical Science; Organic Chemistry; Pharmacology; Medicine (all)
No
Deligia, F; Deiana, V; Gotti, C; Lazzari, P; Bottazzi, Meh; Pucci, L; Fasoli, F; Ragusa, G; Pinna, Gerard Aime; Murineddu, Gabriele
Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors / Deligia, F; Deiana, V; Gotti, C; Lazzari, P; Bottazzi, Meh; Pucci, L; Fasoli, F; Ragusa, G; Pinna, Gerard Aime; Murineddu, Gabriele. - In: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0223-5234. - 103:(2015), pp. 429-437. [10.1016/j.ejmech.2015.09.006]
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
10
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/61111
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact